ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

RMSL RemSleep Holdings Inc (QB)

0.0117
0.00005 (0.43%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
RemSleep Holdings Inc (QB) USOTC:RMSL OTCMarkets Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00005 0.43% 0.0117 0.0101 0.0126 0.0121 0.011 0.011 1,977,162 21:15:15

Exit Report Under Regulation a (1-z)

27/07/2020 10:06pm

Edgar (US Regulatory)


Form 1-Z Issuer Information


FORM 1-Z

UNITED STATE
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 1-Z
EXIT REPORT UNDER REGULATION A

OMB APPROVAL

OMB Number: ####-####

Estimated average burden hours per response: ##.#

1-Z: Filer Information

Issuer CIK
0001412126
Issuer CCC
XXXXXXXX
File Number
Is this filing by a successor company pursuant to Rule 257(b)(5) resulting from a merger or other business combination?
o Yes x No
Successor File Number
Is this a LIVE or TEST Filing?
x LIVE o TEST
Is this an electronic copy of an official filing submitted in paper format?
o
Would you like a Return Copy?
o

Submission Contact Information

Name
Phone
E-Mail Address
Notify via Filing Website only?
o

1-Z: PRELIMINARY INFORMATION

Exact name of issuer as specified in the issuer's charter
REMSLEEP HOLDINGS, INC.
Address of Principal Executive Offices
Address 1
2202 N. West Shore Blvd
Address 2
Suite 200
City
TAMPA
State/Country
FLORIDA
Mailing Zip/ Postal Code
33607
Phone
813-367-3855
Commission File Number(s)
024-11092

1-Z: PART I Summary Information Regarding the Offering and Proceeds

Summary Information

Date of qualification of the offering statement
03-31-2020
Date of commencement of the offering
03-31-2020
Amount of securities qualified to be sold in the offering
600000000
Amount of securities sold in the offering
15000000
Price per security:
$ 0.0050
The portion of aggregate sales attributable to securities sold on behalf of the issuer
$ 75000.00
The portion of aggregate sales attributable to securities sold on behalf of selling securityholders:
$ 0.00

Fees in connection with this offering and names of service providers.

Underwriters - Name of Service Provider
N/A
Underwriters - Fees
$ 0.00
Sales Commissions - Name of Service Provider
N/A
Sales Commissions - Fee
$ 0.00
Finders' Fees - Name of Service Provider
N/A
Finders' Fees - Fees
$ 0.00
Audit - Name of Service Provider
Fruci & Associates II, PLLC
Audit - Fees
$ 1500.00
Legal - Name of Service Provider
Magri Law, LLC
Legal - Fees
$ 15000.00
Promoters - Name of Service Provider
N/A
Promoters - Fees
$ 0.00
Blue Sky Compliance - Name of Service Provider
Magri Law, LLC
Blue Sky Compliance - Fees
$ 0.00
CRD Number of any broker or dealer listed
Net proceeds to the issuer
$ 58500.00
Clarification of responses (if necessary):
The Registrant hereby withdraws its Offering Statement on Form 1-A originally qualified on December 16, 2019 and the Post-Qualification Amendment to such Form 1-A qualified on March 31, 2020.

1-Z: Signature

Signature

Pursuant to the requirements of Regulation A,

Cik
0001412126
(Name of issuer as specified in charter)
RemSleep Holdings Inc.

certifies that it meets all of the conditions for termination of Regulation A reporting specified in Rule 257(d) and that there are no classes of securities other than those that are the subject to this Form 1-Z regarding which the issuer has Regulation A reporting obligations.

(Name of issuer as specified in charter)
RemSleep Holdings Inc.

Has caused this certification to be signed on its behalf by the undersigned duly authorized person.

By
/s/ Thomas Wood
Date
07-27-2020
Title
President (Principal Executive Officer)

Instructions: This Part II of Form 1-Z is required by Rule 257(d) of Regulation A. An officer of the issuer or any other duly authorized person may sign, and must do so by typed signature. The name and title of the person signing the form must be typed or printed under the signature. The signatory to the filing must also manually sign a signature page or other document authenticating, acknowledging or otherwise adopting his or her signature that appears in the filing. Such document must be executed before or at the time the filing is made and must be retained by the issuer for a period of five years. Upon request, the issuer must furnish to the Commission or its staff a copy of any or all documents retained

1 Year RemSleep (QB) Chart

1 Year RemSleep (QB) Chart

1 Month RemSleep (QB) Chart

1 Month RemSleep (QB) Chart

Your Recent History

Delayed Upgrade Clock